Clinical Trial Update: Adult Attention Deficit Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for adults with attention-deficit/hyperactivity disorder has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Adult Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED | Results posted: 2015-01-12